Retatrutide

Description

Retatrutide is a triple hormone receptor agonist, activating GLP-1, GIP, and glucagon receptors in a single molecule. The addition of glucagon receptor activity — absent from earlier incretin analogues — is what distinguishes retatrutide from semaglutide or tirzepatide, since glucagon signalling contributes an energy-expenditure component alongside appetite suppression.

Phase 2 trial data reported substantial reductions in body weight in treated participants, making retatrutide one of the most closely watched next-generation incretin therapies for weight management.

Retatrutide is a prescription-only treatment, not available over the counter. You may be eligible if you have a BMI of 30 or above, or a BMI of 27 or above with a weight-related condition such as high blood pressure or type 2 diabetes. Eligibility is assessed through a medical questionnaire reviewed by our clinical team, and treatment is dispensed only where clinically appropriate and approved by a licensed physician.

How to Order

1. Complete a short online questionnaire so our doctors can assess your suitability for retatrutide.
2. Doctor review and approval — a licensed physician reviews your answers before any prescription is issued. If your order isn’t approved, our team will contact you directly instead of shipping anything.
3. Discreet delivery — approved orders are dispensed and shipped in plain, unmarked packaging.

Side Effects

As with other incretin-based therapies, the most commonly reported side effects are nausea, diarrhoea, and constipation, which usually ease as your body adjusts to the dose. Do not start, stop, or change your dose without direction from your prescriber.

Reconstitute with bacteriostatic water and store refrigerated, protected from light. Use only as directed by your prescriber.